Flow diverter surface modifications for aneurysm treatment: A review of the mechanisms and data behind existing technologies

• Published in: Interventional neuroradiology 2023-10, p.15910199231207550-15910199231207550
• Main Authors: White, Timothy G, Santhumayor, Brandon A, Turpin, Justin, Shah, Kevin, Toscano, Daniel, Teron, Ina, Link, Thomas, Patsalides, Athos, Woo, Henry H
• Format: Article
• Language: English
• ISSN: 1591-0199; 2385-2011
• DOI: 10.1177/15910199231207550

Flow diversion (FD) has become a mainstay treatment for large wide-necked aneurysms. Despite excellent safety and efficacy, the risk of thromboembolic complications necessitates the use of dual antiplatelet therapy (DAPT). The use of DAPT makes hemorrhagic complications of stenting carry high morbidity and mortality. Additionally, DAPT usage carries a risk of “nuisance” complications that do not directly impact intracranial circulation but need to be managed nonetheless. To circumvent this issue, the most recent generation of flow diverters have undergone surface modification with various compounds to confer blood compatibility to limit clotting and thrombosis. While these newer generation flow diverters are marketed to enhance ease of deployment, the goal is to eventually facilitate single antiplatelet use with flow diverter treatment. This generation of FDs have potential to expand indications beyond unruptured wide-necked aneurysms to include ruptured intracranial aneurysms without the necessity of DAPT. Currently, no comprehensive review details the molecular mechanisms and pre-clinical and clinical data on these modifications. We seek to fill this gap in the literature by consolidating information on the coating technology for four major FDs currently in clinical use—Pipeline TM Flex and Vantage Shield Technology TM , FRED TM X, p48/64 hydrophilic coating, and Acandis Dervio® 2heal—to serve as a reference guide in neurointerventional aneurysm treatment. Although the Balt silk TM was one of the first FDs, it is uncoated, thus we will not cover this device in our review. A literature review was performed to obtain information on each coating technology for the major flow diverters currently on the market using international databases (PUBMED, Embase, Medline, Google Scholar). The search criteria used the keywords for each coating technology of interest “phosphorylcholine,” “poly 2-methoxyethyl acrylate,” “hydrophilic polymer coating,” and “fibrin-heparin” Keywords related to the device names “Pipeline Shield,” “Pipeline Shield with Flex Technology,” “FRED,” “FREDX,” “p64,” “p64-HPC,” “Derivo 2heal” were also used. Studies that detailed the mechanism of action of the coating, any pre-clinical studies with surface-modified intravascular devices, and any clinical retrospective series, prospective series, or randomized clinical trials with surface-modified devices for aneurysm treatment were included.